These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27383371)

  • 1. Pathogenesis of Streptococcus urinary tract infection depends on bacterial strain and β-hemolysin/cytolysin that mediates cytotoxicity, cytokine synthesis, inflammation and virulence.
    Leclercq SY; Sullivan MJ; Ipe DS; Smith JP; Cripps AW; Ulett GC
    Sci Rep; 2016 Jul; 6():29000. PubMed ID: 27383371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the Streptococcus agalactiae Virulence Regulator CovR on the Pathogenesis of Urinary Tract Infection.
    Sullivan MJ; Leclercq SY; Ipe DS; Carey AJ; Smith JP; Voller N; Cripps AW; Ulett GC
    J Infect Dis; 2017 Feb; 215(3):475-483. PubMed ID: 28011914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Age, but Not Parity Predisposes to Higher Bacteriuria Burdens Due to Streptococcus Urinary Tract Infection and Influences Bladder Cytokine Responses, Which Develop Independent of Tissue Bacterial Loads.
    Sullivan MJ; Carey AJ; Leclercq SY; Tan CK; Ulett GC
    PLoS One; 2016; 11(12):e0167732. PubMed ID: 27936166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Characterization of Human-Urine Utilization by Asymptomatic-Bacteriuria-Causing Streptococcus agalactiae.
    Ipe DS; Ben Zakour NL; Sullivan MJ; Beatson SA; Ulett KB; Benjamin WH; Davies MR; Dando SJ; King NP; Cripps AW; Schembri MA; Dougan G; Ulett GC
    Infect Immun; 2016 Jan; 84(1):307-19. PubMed ID: 26553467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Hemolysin/cytolysin of Group B Streptococcus enhances host inflammation but is dispensable for establishment of urinary tract infection.
    Kulkarni R; Randis TM; Antala S; Wang A; Amaral FE; Ratner AJ
    PLoS One; 2013; 8(3):e59091. PubMed ID: 23505569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic activity and biofilm-formation among clinical isolates of group B streptococcus causing acute urinary tract infection and asymptomatic bacteriuria.
    Desai D; Goh KGK; Sullivan MJ; Chattopadhyay D; Ulett GC
    Int J Med Microbiol; 2021 Aug; 311(6):151520. PubMed ID: 34273854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection.
    Kline KA; Schwartz DJ; Lewis WG; Hultgren SJ; Lewis AL
    Infect Immun; 2011 Sep; 79(9):3588-95. PubMed ID: 21690238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence properties of asymptomatic bacteriuria Escherichia coli.
    Mabbett AN; Ulett GC; Watts RE; Tree JJ; Totsika M; Ong CL; Wood JM; Monaghan W; Looke DF; Nimmo GR; Svanborg C; Schembri MA
    Int J Med Microbiol; 2009 Jan; 299(1):53-63. PubMed ID: 18706859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.
    Nagamatsu K; Hannan TJ; Guest RL; Kostakioti M; Hadjifrangiskou M; Binkley J; Dodson K; Raivio TL; Hultgren SJ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E871-80. PubMed ID: 25675528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Streptococcus agalactiae Stringent Response Enhances Virulence and Persistence in Human Blood.
    Hooven TA; Catomeris AJ; Bonakdar M; Tallon LJ; Santana-Cruz I; Ott S; Daugherty SC; Tettelin H; Ratner AJ
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29109175
    [No Abstract]   [Full Text] [Related]  

  • 11. Heterogeneity of hemolysin expression during neonatal Streptococcus agalactiae sepsis.
    Sigge A; Schmid M; Mauerer S; Spellerberg B
    J Clin Microbiol; 2008 Feb; 46(2):807-9. PubMed ID: 18077645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.
    Tan CK; Carey AJ; Cui X; Webb RI; Ipe D; Crowley M; Cripps AW; Benjamin WH; Ulett KB; Schembri MA; Ulett GC
    Infect Immun; 2012 Sep; 80(9):3145-60. PubMed ID: 22733575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
    Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcriptional regulator RovS controls the attachment of Streptococcus agalactiae to human epithelial cells and the expression of virulence genes.
    Samen UM; Eikmanns BJ; Reinscheid DJ
    Infect Immun; 2006 Oct; 74(10):5625-35. PubMed ID: 16988238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of RogB-controlled virulence mechanisms and gene repression in Streptococcus agalactiae.
    Gutekunst H; Eikmanns BJ; Reinscheid DJ
    Infect Immun; 2003 Sep; 71(9):5056-64. PubMed ID: 12933848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolation of Streptococcus agalactiae in adults: serotypes, adhesiveness to epithelial cells].
    Cueto M; Carazo C; Rojas A; Bañón R; Rosa M
    Enferm Infecc Microbiol Clin; 1990; 8(7):426-8. PubMed ID: 2152478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CovS/CovR of group B streptococcus: a two-component global regulatory system involved in virulence.
    Lamy MC; Zouine M; Fert J; Vergassola M; Couve E; Pellegrini E; Glaser P; Kunst F; Msadek T; Trieu-Cuot P; Poyart C
    Mol Microbiol; 2004 Dec; 54(5):1250-68. PubMed ID: 15554966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pore-forming toxin β hemolysin/cytolysin triggers p38 MAPK-dependent IL-10 production in macrophages and inhibits innate immunity.
    Bebien M; Hensler ME; Davanture S; Hsu LC; Karin M; Park JM; Alexopoulou L; Liu GY; Nizet V; Lawrence T
    PLoS Pathog; 2012; 8(7):e1002812. PubMed ID: 22829768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virulence role of group B Streptococcus beta-hemolysin/cytolysin in a neonatal rabbit model of early-onset pulmonary infection.
    Hensler ME; Liu GY; Sobczak S; Benirschke K; Nizet V; Heldt GP
    J Infect Dis; 2005 Apr; 191(8):1287-91. PubMed ID: 15776375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione Synthesis Contributes to Virulence of
    Walker EA; Port GC; Caparon MG; Janowiak BE
    J Bacteriol; 2019 Oct; 201(20):. PubMed ID: 31331978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.